450839-69-7Relevant articles and documents
Synthesis and biological evaluation of 1-benzyl-5-(3-biphenyl-2-yl-propyl)- 1H-imidazole as novel farnesyltransferase inhibitor
Lin, Nan-Horng,Wang, Le,Wang, Xilu,Wang, Gary T.,Cohen, Jerry,Gu, Wen-Zhen,Zhang, Haiying,Rosenberg, Saul H.,Sham, Hing L.
, p. 5057 - 5062 (2004)
Analogs of compound 1 were synthesized and tested in vitro for farnesyltransferase inhibition activity.
Synthesis and activity of 1-aryl-1′-imidazolyl methyl ethers as non-thiol farnesyltransferase inhibitors
Li, Qun,Wang, Gary T.,Li, Tongmei,Gwaltney II, Stephen L.,Woods, Keith W.,Claiborne, Akiyo,Wang, Xilu,Gu, Wendy,Cohen, Jerry,Stoll, Vincent S.,Hutchins, Charles,Frost, David,Rosenberg, Saul H.,Sham, Hing L.
, p. 5371 - 5376 (2007/10/03)
A series of imidazole-containing methyl ethers (4-5) have been designed and synthesized as potent and selective farnesyltransferase inhibitors (FTIs) by transposition of the D-ring to the methyl group on the imidazole of the previously reported FTIs 3. Several compounds such as 4h and 5b demonstrate superior enzymatic activity to the current benchmark compound tipifarnib (1) with IC50 values in the lower subnanomolar range, while maintaining excellent cellular activity comparable to tipifarnib. The compounds are characterized as being simple, easier to make, and possess no chiral center involved.
Farnesyltransferase inhibitors
-
, (2008/06/13)
Substituted imidazoles and thiazoles having the formula are useful for inhibiting farnesyltransferase. Also disclosed are farnesyltransferase-inhibiting compositions and methods of inhibiting farnesyltransferase in a patient.
